From: Influenza virus-related critical illness: prevention, diagnosis, treatment
Antiviral agents and age group [64] | Treatment dosing |
---|---|
Oseltamivir | |
 Adults (including pregnancy) | 75 mg twice daily |
 Children (1 year or older) ≤15 kg | 30 mg twice daily |
 Children > 15–23 kg | 45 mg twice daily |
 Children > 23–40 kg | 60 mg twice daily |
 Children > 40 kg | 75 mg twice daily |
 Term Infants 0–11 months* | See details in footnote |
 Preterm infants** | See details in footnote |
Zanamivir | |
 Adults | 10 mg (two 5-mg inhalations), twice daily |
 Children (≥ 7 years) | 10 mg (two 5-mg inhalations), twice daily |
Peramivir | |
 Adults | 600 mg intravenous infusion once, given over 15–30 min |
 Children (2–12 years) | One 12 mg/kg dose, up to 600 mg maximum, intravenous, given over 15–30 min |
 Children (13–17 years) | 600 mg intravenous infusion once, given over 15–30 min |
Baloxavir marboxil*** | |
 Adults and children (12 years or older) ≥40–80 kg | Single dose of 40 mg |
 Adults and children (12 years or older) ≥80 kg | Single dose of 80 mg |